InvestorsHub Logo
Followers 56
Posts 1134
Boards Moderated 1
Alias Born 01/13/2017

Re: None

Saturday, 01/28/2017 12:06:27 AM

Saturday, January 28, 2017 12:06:27 AM

Post# of 203913
We have two massive hammers about to drop in the coming weeks.

First, the efficacy test. We all know what GWPH and AXIM did after efficacy results dropped.

Second, OWCP will drop another 8-K with details of the consulting agreements with the 3 mystery MMJ States. Sure, the agreements are likely for nominal cash value. However, what is the likelihood that a new MMJ state like CA or MA will take a look at OWCP's research and decide that delivery systems like creams or sublingual tablets are preferred over smoking or oils? Can you imagine if CA announced that it's MMJ program would only allow for CBD/HTC compounds to be used via creams or sublingual tablets?

No reputable, thoughtful doctor is going to tell a patient to "take two puffs and call me in the morning". Yes, maybe for patients who just need pain management. But for everyone else, especially children, the delivery method is key. OWCP has 2 proprietary delivery methods ready to go!